Bupropion controlled-release - IntelGenx
At a glance
- Drug Originator Cary Pharmaceuticals; IntelGenx Corp.
- Drug Licenced by Edgemont Pharmaceuticals
- Drug Class Antidepressants; Obesity therapies; Propiophenones; Small molecules; Smoking cessation therapies
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors
- USA Patent Applicants TWI PHARMS
- USA Patents 2
- NDAs 1
- International Patents 1
- Patent Applications 1,256
Disclaimer